Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060941 · ClinicalTrials.gov registry record · NA
Promoting Activity in Cancer Survivors
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 355
- Enrollment target
NCT03060941: Completed NA study, sponsored by University of Texas Southwestern Medical Center.
NCT03060941 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 355 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03060941, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 355 participants
- Enrollment target
Study Summary
A randomized multi-component physical activity intervention for breast cancer survivors.
Primary Outcome
Measure physical activity at baseline and follow-up periods (3- and 6-months post-baseline) and assess percentage of survivors meeting physical activity guideline recommendations.
Interventions
- BEHAVIORAL Physical activity education
- BEHAVIORAL Facility access
- BEHAVIORAL Supervised exercise sessions
- BEHAVIORAL Self-monitoring (Fitbit)
- BEHAVIORAL Active living counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2017-12-04 |
| Est. Completion | 2020-02-28 |
| Phase | NA |
What the finished NCT03060941 record still lists
NCT03060941 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 5 interventions - of which Physical activity education is the first listed.
NCT03060941 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03060941 about?
NCT03060941 is a clinical study titled "Promoting Activity in Cancer Survivors". A randomized multi-component physical activity intervention for breast cancer survivors.
What is the current status of trial NCT03060941?
This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2017-12-04. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03060941?
The interventions under investigation include: Physical activity education (BEHAVIORAL), Facility access (BEHAVIORAL), Supervised exercise sessions (BEHAVIORAL), Self-monitoring (Fitbit) (BEHAVIORAL), Active living counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03060941?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03060941's enrollment target sits among peer trials
355 291st of 2000 higher than 1,710 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- NCT07193511 · 355 participants · Phase 1
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI